Evaluation of Acute and Sub-Acute Toxicity, Oxidative Stress and Molecular Docking of Two Nitrofuranyl Amides as Promising Anti-Tuberculosis Agents

Tuberculosis (TB) remains a widespread infectious disease and one of the top 10 causes of death worldwide. Nevertheless, despite significant advances in the development of new drugs against tuberculosis, many therapies and preventive measures do not lead to the expected favorable health results for various reasons. The aim of this study was to evaluate the acute and sub-acute toxicity and oxidative stress of two selected nitrofuranyl amides with high in vitro antimycobacterial activity. In addition, molecular docking studies were performed on both compounds to elucidate the possibilities for further development of new anti-tuberculosis candidates with improved efficacy, selectivity, and pharmacological parameters. Acute toxicity tests showed that no changes were observed in the skin, coat, eyes, mucous membranes, secretions, and vegetative activity in mice. The histological findings include features consistent with normal histological architecture without being associated with concomitant pathological conditions. The observed oxidative stress markers indicated that the studied compounds disturbed the oxidative balance in the mouse liver. Based on the molecular docking, compound DO-190 showed preferable binding energies compared to DO-209 in three out of four targets, while both compounds showed promising protein-ligand interactions. Thus, both studied compounds displayed promising activity with low toxicity and can be considered for further evaluation and/or lead optimization.

[1]  Gang Liu,et al.  Optimization of nitrofuranyl calanolides for the fluorescent detection of Mycobacterium tuberculosis. , 2022, European journal of medicinal chemistry.

[2]  G. Dobrikov,et al.  Molecular Insight into Mycobacterium tuberculosis Resistance to Nitrofuranyl Amides Gained through Metagenomics-like Analysis of Spontaneous Mutants , 2022, Pharmaceuticals.

[3]  A. Kamal,et al.  Novel linezolid-based oxazolidinones as potent anticandidiasis and antitubercular agents. , 2022, Bioorganic chemistry.

[4]  Kuljit Singh,et al.  Tuberculosis drug discovery: Progression and future interventions in the wake of emerging resistance. , 2021, European journal of medicinal chemistry.

[5]  Praveen Sharma,et al.  Glutathione deficiency in COVID19 illness-does supplementation help? , 2021, Saudi journal of anaesthesia.

[6]  J. Rakonjac,et al.  Nitrofurans: Revival of an “old” drug class in the fight against antibiotic resistance , 2021, PLoS pathogens.

[7]  V. Charushin,et al.  Renaissance of 4-(5-nitrofuran-2-yl)-5-arylamino substituted pyrimidines: microwave-assisted synthesis and antitubercular activity , 2021 .

[8]  Yalew Molla,et al.  Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia , 2021, Hepatic medicine : evidence and research.

[9]  Sai Ma,et al.  Lipid peroxidation aggravates anti-tuberculosis drug-induced liver injury: Evidence of ferroptosis induction. , 2020, Biochemical and biophysical research communications.

[10]  Ayesha Afzal,et al.  Comparison of hepatoprotective effect of aqueous and ethanolic extracts of Berberis lycium Royale (Sumbloo) in isoniazid induced hepatotoxicity in male mice model , 2020 .

[11]  D. Sriram,et al.  Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. , 2020, European journal of medicinal chemistry.

[12]  Ricky B. Nellas,et al.  Potential Inhibitors of Galactofuranosyltransferase 2 (GlfT2): Molecular Docking, 3D-QSAR, and In Silico ADMETox Studies , 2019, Scientific Reports.

[13]  M. A. Mohamed,et al.  Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents. , 2019, Bioorganic chemistry.

[14]  B. Halliwell,et al.  Mini-Review: Oxidative stress, redox stress or redox success? , 2018, Biochemical and biophysical research communications.

[15]  Yu Lu,et al.  Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents. , 2018, Bioorganic & medicinal chemistry.

[16]  R. Jain,et al.  New structural classes of antituberculosis agents , 2018, Medicinal research reviews.

[17]  S. Wicha,et al.  Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models , 2017, CPT: pharmacometrics & systems pharmacology.

[18]  Xiaochao Ma,et al.  Isoniazid metabolism and hepatotoxicity , 2016, Acta Pharmaceutica Sinica B.

[19]  Hongli Guo,et al.  Hepatotoxicity mechanisms of isoniazid: A mini‐review , 2015, Journal of applied toxicology : JAT.

[20]  Sonali S. Bharate,et al.  Nitrofuranyl Methyl Piperazines as New Anti-TB Agents: Identification, Validation, Medicinal Chemistry, and PK Studies. , 2015, ACS medicinal chemistry letters.

[21]  R. Bains,et al.  The antioxidant master glutathione and periodontal health , 2015, Dental research journal.

[22]  S. Field Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment? , 2015, Therapeutic advances in chronic disease.

[23]  Lisa K. Woolhiser,et al.  Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis , 2014, PloS one.

[24]  Ying Chen,et al.  Glutathione defense mechanism in liver injury: insights from animal models. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[25]  D. Arome,et al.  A New Method for Determining Acute Toxicity in Animal Models , 2013, Toxicology international.

[26]  Abhimanyu K. Singh,et al.  Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents. , 2011, Bioorganic & medicinal chemistry letters.

[27]  V. Nachiappan,et al.  Glutathione peroxidase3 of Saccharomyces cerevisiae protects phospholipids during cadmium-induced oxidative stress , 2011, Antonie van Leeuwenhoek.

[28]  V. Nachiappan,et al.  Cadmium-induced oxidative stress in Saccharomyces cerevisiae. , 2010, Indian journal of biochemistry & biophysics.

[29]  J. Buolamwini,et al.  Quantitative structure-activity relationship studies on nitrofuranyl anti-tubercular agents. , 2008, Bioorganic & medicinal chemistry.

[30]  B. Meibohm,et al.  Pharmacokinetically-Guided Lead Optimization of Nitrofuranylamide Anti-Tuberculosis Agents , 2008, The AAPS Journal.

[31]  Irfan Rahman,et al.  Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method , 2006, Nature Protocols.

[32]  K. Yasui,et al.  Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation , 2006, Inflammation Research.

[33]  P. V. van Helden,et al.  Total Antioxidant Levels are Low During Active TB and Rise with Anti‐tuberculosis Therapy , 2004, IUBMB life.

[34]  L. Marnett,et al.  Malondialdehyde, a Product of Lipid Peroxidation, Is Mutagenic in Human Cells* , 2003, Journal of Biological Chemistry.

[35]  V. Savov,et al.  Antioxidant Properties of Rimantadine in Influenza Virus Infected Mice and in Some Model Systems , 2000, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[36]  Y. Tampo [Studies on membrane factors in iron-supported lipid peroxidation]. , 2000, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[37]  D. Lorke A new approach to practical acute toxicity testing , 1983, Archives of Toxicology.

[38]  I. Fridovich,et al.  Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. , 1971, Analytical biochemistry.

[39]  R. Lillie STUDIES ON HISTOCHEMICAL ACYLATION PROCEDURES. I. PHENOLS , 1964, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  J. H. Sterner,et al.  Tabulation of toxicity classes. , 1949, American Industrial Hygiene Association quarterly.

[41]  Marylee V. Worley,et al.  Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug‐Resistant Tuberculosis , 2014, Pharmacotherapy.

[42]  Kalyana Sundram,et al.  Phenolic compounds in plants and agri-industrial by-products: Antioxidant activity, occurrence, and potential uses , 2006 .

[43]  V. A. Kangralkar,et al.  OXIDATIVE STRESS AND DIABETES: A REVIEW , 2005 .